The search for the earliest signs of Alzheimer's
These PET images show the uptake of a radiotracer called C-11 PIB. Images A and B are in a horizontal plane, C is a vertical slice of the front of the brain, and D is from the side. The reformatting of these planes allows precise localization of the uptake of the tracer. Hotter colors indicate greater uptake consistent with deposition of beta-amyloid in the frontal lobes (yellow arrow in B and D) and the medial parietal lobe (red arrow in D). Credit: Jagust Group
(Medical Xpress) -- For the past five years, volunteers from the City of Berkeley and surrounding areas have come to Lawrence Berkeley National Laboratory to participate in an ongoing study thats changing what scientists know about Alzheimers disease.
The volunteers, most over the age of 70, undergo what can best be described as a brain checkup. Theyre asked to solve puzzles and memorize lists of words. Magnetic resonance imaging (MRI) scans image the structure of their brains in exquisite detail. Functional MRI scans allow scientists to watch portions of their brains light up as they form memories. And Positron emission tomography (PET) scans measure any accumulation of beta-amyloid, a destructive protein thats a hallmark of Alzheimers.
The goal of the Berkeley Aging Cohort Study is to reveal how our brains change as we age. The scientists also compare their findings with brain scans of Alzheimers patients.
Theyve noticed something oddand perhaps a little hopeful. Some volunteers have the same level of beta-amyloid deposition as an Azheimers patient. Yet they show no signs of the disease.
Why is this? How can two people, the same age and with the same signs of the disease, take such different paths?
It turns out that Alzheimers is more complicated than we thought, says William Jagust, a faculty senior scientist in the Berkeley Labss Life Sciences Division who also has appointments at UC Berkeleys School of Public Health and the Helen Wills Neuroscience Institute.
Jagust heads a team that conducts the cohort study, which so far includes about 80 volunteers, with more to come. Their research has put them at the forefront of a more nuanced take on Alzheimers.
Jagust’s group recently acquired a new Siemens Biograph 6 combined PET and computed tomography (CT) scanner. The PET scans measure the uptake of the C-11 PIB radiotracer that targets beta-amyloid. The CT scans are used to assist in the reconstruction of the PET images.Until recently, we thought the more amyloid accumulation in the brain, the greater the chance of developing the disease says Jagust. But we now believe that amyloid unleashes a chain of events that may or may not cause Alzheimers.
Its well known that many normal, older people have some beta-amyloid deposits in their brain. Its also likely true that people with beta-amyloid have a greater risk of cognitive decline and Alzheimers.
But the picture gets cloudy from there. Jagusts group has found structural and functional changes in the brains of healthy people that are associated with beta-amyloid. Some of these changes may be a prelude to Alzheimers.
And some changes may be signs that a person is actually resisting this path.
In a recent study, Jagust and colleagues asked people to commit pictures to memory while they watched their brain activity with functional MRI. Normal people with beta-amyloid deposition showed morenot lessactivity than people without beta-amyloid. One possible interpretation for this heightened activity is that it enables memory formation despite the presence of beta-amyloid. Their brains are working harder.
Were beginning to detect changes that may help people ward off cognitive decline and possibly Alzheimers, says Jagust.
These images were obtained using functional MRI scans taken as cognitively normal people performed tasks that required them to pay attention to changing stimuli. Yellow/orange regions indicate brain areas that become active during the task. Blue regions become less active during the task. In people with evidence of beta-amyloid in the brain, these areas of deactivation are abnormal, meaning they don't fully deactivate. Credit: Bill Jagust's groupJagusts group is pursuing other questions: Is the cognitive decline associated with beta-amyloid deposition linked to the rate of deposition? Or is it more closely associated with changes in brain function that occur after beta-amyloid has done its damage?
Or perhaps cognitive decline is most closely associated with changes in brain structure. In another study, Jagusts team found that the more beta-amyloid plaque in a persons brain, the more a person is likely to have a smaller hippocampus, which is the part of the brain that forms new memories. They also found that someone with this damage is more likely to have impaired memory.
This research will help scientists determine how this constellation of eventsbeta-amyloid deposition, changes in brain function, hippocampus atrophycontributes to Alzheimers.
The search for the earliest signs of the disease has gained importance in recent years as pharmaceutical companies work to develop drug therapies that are designed to block the deposition of beta-amyloid.
There is a strong belief that Alzheimers must be treated very early, before symptoms appear, in order to be effective, says Jagust. We know that amyloid leads to negative consequences in the brain. We now need to determine how to stop these effects before they happen.
Provided by Lawrence Berkeley National Laboratory
- New research dashes notions of benign brain plaque May 22, 2012 | not rated yet | 0
- Malfunctioning protein a cause of Alzheimer's plaques Jun 30, 2011 | not rated yet | 0
- Falls may be early sign of Alzheimer's Jul 18, 2011 | not rated yet | 0
- Putting top brains to the test with Alzheimer's protein Jan 31, 2011 | not rated yet | 0
- Amyloid beta in the brain of individuals with Alzheimer's disease Mar 30, 2012 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Electric field between parallel plate capacitor
1 hour ago If you have an infinite non-conducting plate, the electric field just outside is equal to sigma / 2*epsilon. The electric field just outside a...
Why angle of projectile has 2 solutions?
2 hours ago I have the final answer of: sin2(theta) = 0.871 why does (theta) = 30.3 deg OR (theta) = 59.7 deg I get why this could be physically, but...
How much negative charge do I accumulate by touching the earth?
3 hours ago The Earth carries a negative electric charge of roughly 500 thousand Coulombs (according to different sources I've seen). If I touch the Earth I...
Indeterminism in Classical Physics
9 hours ago I was reading the Roger Penrose book Emperor's New Mind and he was explaining the determinism in Newtonian mechanics. He says that if we consider...
Current in two wires
9 hours ago Wire A and B, which have the same cross-sectional area are connected in series. There is a p.d. V across the whole wire. Suppose the two wires...
understanding the dipole model for Rayleigh scattering
11 hours ago Hello. I am currently studying scattering theory in detail for my BSc thesis, and I'm starting with Rayleigh scattering. I'm following Scattering...
- More from Physics Forums - Classical Physics
More news stories
In the search for medication against Alzheimer's disease, scientists have focused – among other factors – on drugs that can break down Amyloid beta (A-beta). After all, it is the accumulation of A-beta that causes the ...
Alzheimer's disease & dementia 7 hours ago | not rated yet | 0
(Medical Xpress)—The way Alzheimer's disease is portrayed by advocacy groups and the media is having undue influence on the euthanasia debate, according to a Deakin University nursing ethics professor.
Alzheimer's disease & dementia 8 hours ago | not rated yet | 1
Cinnamon: Can the red-brown spice with the unmistakable fragrance and variety of uses offer an important benefit? The common baking spice might hold the key to delaying the onset of –– or warding off ...
Alzheimer's disease & dementia May 23, 2013 | 5 / 5 (5) | 0 |
An anti-cancer drug reverses memory deficits in an Alzheimer's disease mouse model, University of Pittsburgh Graduate School of Public Health researchers confirm in the journal Science.
Alzheimer's disease & dementia May 23, 2013 | not rated yet | 0 |
Teams of highly respected Alzheimer's researchers failed to replicate what appeared to be breakthrough results for the treatment of this brain disease when they were published last year in the journal Science.
Alzheimer's disease & dementia May 23, 2013 | 3 / 5 (2) | 3 |
Talking on a hands-free device while behind the wheel can lead to a sharp increase in errors that could imperil other drivers on the road, according to new research from the University of Alberta.
58 minutes ago | not rated yet | 0
Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...
1 hour ago | 5 / 5 (1) | 0 |
(Medical Xpress)—A new study by researchers in the US has shown that an ancient virus can be modified to help in the fight against the simian immunodeficiency virus SIV, which is the equivalent in monkeys ...
7 hours ago | 5 / 5 (3) | 0 |
Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.
4 hours ago | 5 / 5 (1) | 0 |
Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to ...
4 hours ago | 5 / 5 (2) | 0 |
(Medical Xpress)—Regulating the distribution of power in neurons is done by a system that makes the national electric grid look simple by comparison. Each neuron has several thousand mitochondria confined ...
22 hours ago | 4.9 / 5 (9) | 0 |